Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,125.8, with a 24-hour trading volume of $3.92B. The asset's market cap is $1T, after moving -0.57% in the last day.
Tokenized Eli Lilly And Co is trading at $1,127.57, with a tokenized market cap of $42.88M and a 24-hour trading volume of $3.73M. The tokenized asset has moved -5.94% in the past 24 hours.